Mel Spigelman – Biography
Last update: April 28, 2026Executive profile
Mel was President and Chief Executive Officer for Global Alliance for TB Drug DevelopmentGlobal Alliance for TB Drug Development. Mel Spigelman joined AN2 Therapeutics in 2022.
Mel Spigelman is currentlyDirector at AN2 Therapeutics - View - AN2 Therapeutics org chart
Create your alert
to follow the career of Mel Spigelman.
Education
In 1970, Mel Spigelman completed a Bachelor of Arts in Engineering at University of Maryland.
They have also studied at University of Maryland :
Find more alumni from University of Maryland
More about Mel Spigelman
Selected links
Do you need to know more about Mel Spigelman? More results.
Participate
Social media
- Mel Spigelman on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Mel Spigelman
The colleagues of Mel Spigelman
Company Colleagues
- At AN2 Therapeutics, Mel Spigelman has 12 colleagues including Eric Easom (CEO & Chairman), Lynn Marks (Director)…
Homonyms
- Mel Spigelman - Venture Partner - Wellington Partners
Industry Colleagues
- In the Pharmaceuticals industry, Mel Spigelman has 22,991 colleagues in 1,914 companies located in 68 countries. 10,852 executive movements have been recorded in the last 12 months. Learn more about Pharmaceuticals.
Report an error
Update the org chart details of Mel Spigelman.
Get in Touch
Here are a few tips for establishing great contacts.
